Eric Brandt - Macerich Independent Director
| MAC Stock | USD 19.72 0.16 0.82% |
Director
Mr. Eric K. Brandt is Independent Director of the company. He served as the Executive Vice President and Chief Financial Officer of Broadcom Corporationrationration, a global supplier of semiconductor devices, from February 2010 to February 2016, and served as Broadcoms Senior Vice President and Chief Financial Officer from March 2007 to February 2010. From September 2005 until March 2007, Mr. Brandt served as President, Chief Executive Officer and member of the Board of Directors of Avanir Pharmaceuticals, Inc. Beginning in 1999, he held various positions at Allergan, Inc., a global specialty pharmaceutical company, including Executive Vice President of Finance and Technical Operations and Chief Financial Officer. Prior to joining Allergan, Mr. Brandt spent ten years with The Boston Consulting Group, a privately held global business consulting firm. In January 2017, Mr. Brandt was elected chairman of the board of Altaba Inc. after serving as a member of the board since March 2016 and serves as chair of its audit and nominating and corporate governance committees and as a member of its compensation committee. Mr. Brandt is also chairman of the board and a member of the nominating and corporate governance committee of Dentsply Sirona Inc., a dental products company. He is also a member of the board of directors of Lam Research Corporationrationration, a wafer fabrication equipment company, serving as its audit committee chair. Mr. Brandt currently serves as a member of the Georgia Tech Presidents Advisory Board. since 2018.
| Age | 58 |
| Tenure | 6 years |
| Address | 401 Wilshire Boulevard, Santa Monica, CA, United States, 90401-1452 |
| Phone | 310 394 6000 |
| Web | https://www.macerich.com |
Eric Brandt Latest Insider Activity
Tracking and analyzing the buying and selling activities of Eric Brandt against Macerich stock is an integral part of due diligence when investing in Macerich. Eric Brandt insider activity provides valuable insight into whether Macerich is net buyers or sellers over its current business cycle. Note, Macerich insiders must abide by specific rules, including filing SEC forms every time they buy or sell Macerich'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Eric Brandt over six months ago Acquisition by Eric Brandt of tradable shares of Dentsply Sirona subject to Rule 16b-3 |
Macerich Management Efficiency
Macerich's management efficiency ratios could be used to measure how well Macerich manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Valerie Richardson | Kimco Realty | 62 | |
| W Lehmkuhl | Agree Realty | 48 | |
| Philip Coviello | Kimco Realty | 77 | |
| George Clancy | Saul Centers | 77 | |
| Linda Abraham | Site Centers Corp | 58 | |
| Gabrielle Sulzberger | Brixmor Property | 60 | |
| David Fick | National Retail Properties | 63 | |
| Craig Erlich | Agree Realty | 56 | |
| Frank Lourenso | Kimco Realty | 80 | |
| Pamela Beall | National Retail Properties | 64 | |
| Julie Bowerman | Brixmor Property | 52 | |
| Dawn Sweeney | Site Centers Corp | 61 | |
| Brian Hawthorne | Agree Realty | N/A | |
| Reginald Gilyard | Realty Income | 57 | |
| Farris Kalil | Agree Realty | 81 | |
| Henry Moniz | Kimco Realty | 56 | |
| Colombe Nicholas | Kimco Realty | 75 | |
| Andrew Saul | Saul Centers | 55 | |
| Josh Bratton | Agree Realty | N/A | |
| Thomas Finne | Site Centers Corp | 61 | |
| Jane DeFlorio | Site Centers Corp | 50 | |
Management Performance
| Return On Equity | 0.0348 | ||||
| Return On Asset | 0.0059 |
Macerich Leadership Team
Elected by the shareholders, the Macerich's board of directors comprises two types of representatives: Macerich inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Macerich. The board's role is to monitor Macerich's management team and ensure that shareholders' interests are well served. Macerich's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Macerich's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kurt Ivey, Senior Marketing | ||
| Thomas CPA, CEO Director | ||
| Steven Soboroff, Independent Director | ||
| John Alschuler, Independent Director | ||
| Ann JD, Chief EVP | ||
| Robert Beffa, Senior Estate | ||
| David Short, Executive Management | ||
| Peggy Alford, Independent Director | ||
| Tom Birdsall, Senior Technology | ||
| Douglas Healey, Senior Executive Vice President, Head of Leasing | ||
| Diana Laing, Independent Director | ||
| Eric Brandt, Independent Director | ||
| Edward Coppola, President, Director | ||
| Ann Menard, Executive Vice President Chief Legal Officer and Secretary | ||
| Michael Slavin, Senior Technology | ||
| Samantha Greening, Director Relations | ||
| Daniel Hirsch, Independent Director | ||
| William Voegele, Executive Vice President Chief Development Officer | ||
| J Jones, Senior Technology | ||
| Thomas OHern, CFO, Senior Executive Vice President Treasurer | ||
| Christopher Zecchini, Senior Vice President Chief Accounting Officer, Principal Accounting Officer | ||
| Kenneth Volk, Executive Vice President of Business Development | ||
| Tom Unis, Senior Relations | ||
| Steven Hash, Independent Chairman of the Board | ||
| Scott Kingsmore, Chief Financial Officer, Senior Executive Vice President, Treasurer | ||
| Jamie Bourbeau, Senior Division | ||
| Olivia Leigh, Executive People | ||
| Daniel II, Treasurer CFO | ||
| Jackson Hsieh, President CEO | ||
| Andrea Stephen, Independent Director |
Macerich Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Macerich a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0348 | ||||
| Return On Asset | 0.0059 | ||||
| Profit Margin | 0.10 % | ||||
| Operating Margin | 0.14 % | ||||
| Current Valuation | 8.75 B | ||||
| Shares Outstanding | 225.53 M | ||||
| Shares Owned By Insiders | 0.69 % | ||||
| Shares Owned By Institutions | 96.39 % | ||||
| Number Of Shares Shorted | 12.94 M | ||||
| Price To Earning | 53.00 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Macerich offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Macerich's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Macerich Company Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Macerich Company Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Macerich Company. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Retail REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Macerich. If investors know Macerich will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Macerich listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 39.711 | Dividend Share 0.68 | Earnings Share 0.36 | Revenue Per Share 3.639 | Quarterly Revenue Growth (0.03) |
The market value of Macerich is measured differently than its book value, which is the value of Macerich that is recorded on the company's balance sheet. Investors also form their own opinion of Macerich's value that differs from its market value or its book value, called intrinsic value, which is Macerich's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Macerich's market value can be influenced by many factors that don't directly affect Macerich's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Macerich's value and its price as these two are different measures arrived at by different means. Investors typically determine if Macerich is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Macerich's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.